Works matching IS 03057453 AND DT 1998 AND VI 42 AND IP 4

Results: 43

Pharmacokinetics, safety and anti-human immunodeficiency virus (HIV) activity of hydroxyurea in combination with didanosine.

Published in:

1998

By:

Luzzati, R;
Di Perri, G;
Fendt, D;
Ramarli, D;
Broccali, G;
Concia, E

Publication type:

clinical trial

Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin.

Published in:

1998

By:

De Turck, B J;
Diltoer, M W;
Cornelis, P J;
Maes, V;
Spapen, H D;
Camu, F;
Huyghens, L P

Publication type:

Case Study

Emergence in vivo of resistance to ampicillin in a clinical isolate of Enterococcus hirae.

Published in:

1998

By:

Massa, R;
Bantar, C;
Mollerach, M;
Nicola, F;
Murray, B E;
Smayevsky, J;
Gutkind, G

Publication type:

Letter

In-vitro activity of a novel penem, Men 10700, against meningococci and gonococci, and the effect of a cysteine-containing supplement.

Published in:

1998

By:

Hamilton-Miller, J M;
Shah, S

Publication type:

Letter

Decrease in antibiotic susceptibility or increase in resistance?--defects of present antimicrobial susceptibility surveillance.

Published in:

1998

By:

MacGowan, A;
Bennett, P

Publication type:

commentary

Antimicrobial activity of the semisynthetic compound, hexahydrocolupulone.

Published in:

1998

By:

Stephan, T E;
Ngo, E O;
Ferrieri, P;
Besser, J M;
Nutter, L M

Publication type:

journal article

Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).

Published in:

1998

By:

Biron, P;
Fuhrmann, C;
Cure, H;
Viens, P;
Lefebvre, D;
Thyss, A;
Viot, M;
Soler-Michel, P;
Rollin, C;
Grès, J J

Publication type:

journal article

Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.

Published in:

1998

By:

Gazouli, M;
Tzouvelekis, L S;
Vatopoulos, A C;
Tzelepi, E

Publication type:

journal article

Modulation of the pro- and anti-inflammatory cytokine balance by amphotericin B.

Published in:

1998

By:

Vonk, AG;
Netea, MG;
Denecker, NEJ;
Verschueren, ICMM;
van der Meer, JWM;
Kullberg, BJ;
Vonk, A G;
Netea, M G;
Denecker, N E;
Verschueren, I C;
van der Meer, J W;
Kullberg, B J

Publication type:

journal article

In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii.

Published in:

1998

By:

Cirioni, C;
Giacometti, A;
Barchiesi, F;
Scalise, G;
Cirioni, O

Publication type:

journal article

Extended-spectrum beta-lactamases: the role of inhibitors in therapy.

Published in:

1998

By:

Amyes, S G;
Miles, R S

Publication type:

journal article

Leading article. Extended-spectrum β-lactamases: the role of inhibitors in therapy.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 415, doi. 10.1093/jac/42.4.415

By:

Amyes, SGB;
Miles, RS

Publication type:

Article

Response of single species biofilms and microcosm dental plaques to pulsing with chlorhexidine.

Published in:

1998

By:

Pratten, J;
Smith, AW;
Wilson, M;
Smith, A W

Publication type:

journal article

Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.

Published in:

1998

By:

Davey, KG;
Szekely, A;
Johnson, EM;
Warnock, DW;
Davey, K G;
Johnson, E M;
Warnock, D W

Publication type:

journal article

Original articles. Transferable class C β-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC β-lactamase.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 419, doi. 10.1093/jac/42.4.419

By:

Gazouli, M;
Tzouvelekis, LS;
Vatopoulos, AC;
Tzelepi, E

Publication type:

Article

In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem.

Published in:

1998

By:

Sakagawa, E;
Otsuki, M;
Ou, T;
Nishino, T;
Oh, T

Publication type:

journal article

Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans.

Published in:

1998

By:

Bowker, KE;
Holt, HA;
Lewis, RJ;
Reeves, DS;
McGowan, AP;
Bowker, K E;
Holt, H A;
Lewis, R J;
Reeves, D S;
MacGowan, A P

Publication type:

journal article

Inhibitors of branched-chain amino acid biosynthesis as potential antituberculosis agents.

Published in:

1998

By:

Grandoni, JA;
Marta, PT;
Schloss, JV;
Grandoni, J A;
Marta, P T;
Schloss, J V

Publication type:

journal article

Treatment of disseminated Mycobacterium genavense infection in a murine model with ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin.

Published in:

1998

By:

Vrioni, G;
Nauciel, C;
Kerharo, G;
Matsiota-Bernard, P

Publication type:

journal article

The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.

Published in:

1998

By:

Schmitz, F-J;
Lindenlauf, E;
Hofmann, B;
Fluit, AC;
Verhoef, J;
Heinz, H-P;
Jones, ME;
Fluit, A C;
Jones, M E

Publication type:

journal article

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 497, doi. 10.1093/jac/42.4.497

By:

Lass-Flö, C;
Kofler, G;
Kropshofer, G;
Hermans, J;
Kreczy, A;
Dierich, MP;
Niederwieser, D

Publication type:

Article

Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.

Published in:

1998

By:

Cuenca-Estrella, M;
Rodriguez-Tudela, JL;
Mellado, E;
Martinez-Suárez, YV;
Monzón, A;
Rodríguez-Tudela, J L;
Martínez-Suárez, J V

Publication type:

journal article

Cefepime versus impipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 511, doi. 10.1093/jac/42.4.511

By:

Biron, P;
Fuhrmann, C;
Cure, H;
Viens, P;
Lefebvre, D;
Thyss, A;
Viot, M;
Soler-Michel, P;
Rollin, C;
Grès, J-J;
CEMIC

Publication type:

Article

Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.

Published in:

1998

By:

Norrby, SR;
Geddes, AM;
Shah, PM;
Norrby, S R;
Geddes, A M;
Shah, P M

Publication type:

journal article

Comparative activity of trovafloxacin and Bay 12-8039 against 452 clinical isolates of Streptococcus pneumoniae.

Published in:

1998

By:

Weiss, K;
Laverdiere, M;
Restieri, C

Publication type:

journal article

Brief reports. Antimicrobial activity of the semisynthetic compound, hexahydrocolupulone.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 519, doi. 10.1093/jac/42.4.519

By:

Stephan, TE;
Ngo, EO;
Ferrieri, P;
Besser, JM;
Nutter, LM

Publication type:

Article

Reply.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 548

By:

Walker, RD;
Thornsberry, C

Publication type:

Article

Penetration of ceftazidime into bone from severely ischaemic limbs.

Published in:

1998

By:

Raymakers, JTFJ;
Schaper, NC;
van der Heyden, JJ;
Tordoir, JHM;
Kitslaar, PJEHM;
Raymakers, J T;
Schaper, N C;
van der Heyden, J J;
Tordoir, J H;
Kitslaar, P J

Publication type:

journal article

Susceptibility of penicillin-susceptible and -resistant pneumococci to CFC-222, a new fluoroquinolone.

Published in:

1998

By:

Kim, JH;
Kang, JA;
Lee, Y;
Lee, KH;
Lee, JH;
Choi, EC;
Kim, BK;
Kim, J H;
Kang, J A;
Lee, K H;
Lee, J H;
Choi, E C;
Kim, B K

Publication type:

journal article

Letter. In-vitro activities of cefepime and other Β-lactam antibiotics against clincal isolates from a Colombian teaching hospital.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 550, doi. 10.1093/jac/42.4.550

By:

Mattar, S;
Sánchez, L;
Pérez, D;
Arango, A;
Parodi, R;
Muelle, C

Publication type:

Article

Letter. Decrease in antibiotic susceptibility or increase in resistance? - defects of present antimicrobial susceptibility surveillance.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 547

By:

McGowan, A;
Bennett, P

Publication type:

Article

Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction.

Published in:

1998

By:

Miró, E;
del Cuerpo, M;
Navarro, F;
Sabaté, M;
Mirelis, B;
Prats, G

Publication type:

journal article

SCH56592 treatment of murine invasive aspergillosis.

Published in:

1998

By:

Graybill, JR;
Bocanegra, R;
Najvar, LK;
Luthe, MF;
Loebenberg, D;
Graybill, J R;
Najvar, L K;
Luther, M F

Publication type:

journal article

Letter. In-vitro activity of two oral β-lactams (cefpoxodime and amoxycillin) against Streptococcus pneumoniae isolates with reduced susceptibilities to penicillin.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 555, doi. 10.1093/jac/42.4.555

By:

Johnson, DM;
Jones, RN

Publication type:

Article

Letter. In-vitro activity of DU-6859a against methicillin-restant Staphylococcus aureus isolates with reduced susceptibilities to vancomycin.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 552

By:

Tanak, M;
Wada, N;
Kurosaka, SM;
Chiba, M;
Sato, K;
Hiramatsu, K

Publication type:

Article

Letter. In-vitro activity of a novel penem, Men 10700, against meningococci and gonococci, and the effect of a cysteine-containing supplement.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 553, doi. 10.1093/jac/42.4.553

By:

Hamilton-Miller, JMT;
Sha, S

Publication type:

Article

Letter. Pharmacokinetics, safety and anti-human immunodeficiecy virus (HIV) activity of hydroxyurea in combination with didanosine.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 565, doi. 10.1093/jac/42.4.565

By:

Luzzati, R;
Di Perri, G;
Fendt, D;
Ramarli, D;
Broccali, G;
Concia, E

Publication type:

Article

Letter. Relationship between mutations in coding the promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 561, doi. 10.1093/jac/42.4.561

By:

Schmitz, F-J;
Hertel, B;
Hofmann, B;
Scheuring, S;
Vanhoef, J;
Fluit, AC;
Heinz, H-P;
Köhrer, K;
Jones, ME

Publication type:

Article

Letter. Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 563, doi. 10.1093/jac/42.4.563

By:

De Turck, BJG;
Diltoer, MW;
Cornelis, PJww;
Maes, V;
Spapen, HDM;
Camu, F;
Huyghens, LP

Publication type:

Article

Letter. Emergence in vivo of restance to ampicillin in a clinical isolate of Enterococcus hirae.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 559, doi. 10.1093/jac/42.4.559

By:

Massa, R;
Bantar, C;
Mollerach, M;
Nicola, F;
Murray, BE;
Smayevsky, J;
Gutkind, G

Publication type:

Article

Letter. Antibiotic susceptibilities of verocytotoxin-producing Escherichia coli O157 and non-O157 strains isolated from patients and healthy subjects in Germany during 1996.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 548a, doi. 10.1093/jac/42.4.548

By:

Schmidt, H;
von Maldeghem, J;
Frosch, M;
Karch, H

Publication type:

Article

Letter. Antimicrobial interactions of trovafloxacin and extended-spectrum cephlosporins or azithromycin tested against clinical isolates of Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 557, doi. 10.1093/jac/42.4.557

By:

Johnson, DM;
JOnes, RN;
Pfaller, MA

Publication type:

Article

Book reviews.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 1998, v. 42, n. 4, p. 567

By:

Various

Publication type:

Article